Jimi

Jimi

Sickle Cell Disease

Jimi, a technology entrepreneur from Atlanta, recently became the world’s first patient with sickle cell disease to summit Mount Kilimanjaro. Jimi took part in SCRI’s CRISPR clinical trial, which is now FDA approved for specific indications, to combat his sickle cell disease which often left him with pain crises and frequent hospitalizations. He received care at Sarah Cannon Research Institute; TriStar Centennial Children’s Hospital under the care of Dr. Haydar Frangoul. Jimi was treated with the CRISPR therapy in fall 2020.

Patients with sickle cell disease are at serious risk of complications and death in low-oxygen environments; doctors advise against entering an elevation of 10,000+ feet. Jimi, now functionally cured, summited Kilimanjaro at 19,341 feet in September 2024! Take a peek at his journey here.